Health Care

Miami-based wholesalers are accused of selling black-market prescription drugs to pharmacies

Federal prosecutors indicted two pharmaceutical company executives, accusing them of selling prescription drugs from the black market to unwitting pharmacies and consumers. File photo.
Federal prosecutors indicted two pharmaceutical company executives, accusing them of selling prescription drugs from the black market to unwitting pharmacies and consumers. File photo.

Federal prosecutors indicted two pharmaceutical-company executives on Friday, accusing them of selling millions of dollars’ worth of prescription drugs from the black market to unwitting pharmacies and consumers as part of a scheme that operated for six months out of a Miami apartment.

The U.S. Attorney’s Office for the Southern District of Florida said it has indicted Joshua Ryan Joles, the chief executive officer of Wholesale Supply LLC, and Mohammad Mehdi Salemi, the chief executive officer of Wholesalers Group, Inc. and Wholesalers Group LLC, as well as two bank-account holders on charges relating to money laundering, mail fraud, and violating the federal Food, Drug and Cosmetic Act.

Prosecutors accused Joles and Salemi of purchasing and distributing brand-name drugs acquired through an underground market. The drugs treated conditions such as mental illness, HIV, and cancer and were acquired unlawfully through fraud, pharmacy burglaries, and cargo thefts, according to the indictment.

“The allegations set forth in this scheme strike at the peace of mind we should all feel when we buy prescription drugs from a pharmacy,” said U.S. Attorney Ariana Farjardo Orshan. “We all expect and should rest assured knowing that the drugs we are buying are safe, effective, and properly stored and handled.”

Defense-lawyer information for Joles and Salemi was not immediately available. The two men have yet to appear before a federal judge.

According to the indictment, Joles and Salemi established seemingly legitimate wholesale companies and bank accounts, produced fraudulent paperwork, and professionally packaged and shipped the medicines to pharmacies.

“This investigation into a South Florida based drug diversion group spanned the entire country, from California to Puerto Rico,” said George L. Piro, special agent in charge of the FBI’s Miami Field Office. “It is truly an example of multiple federal and state agencies working together with private industry to take out of circulation thousands of bottles of potentially dangerous drugs, and also disrupt a money laundering scheme that moved millions of dollars a month through South Florida.”

Joles and Salemi could not be reached for comments.

This story was originally published October 18, 2019 at 4:51 PM.

Ben Conarck
Miami Herald
Ben Conarck joined the Miami Herald as a healthcare reporter in August 2019 and led the newspaper’s award-winning coverage on the coronavirus pandemic. He is a member of the investigative team studying the forensics of Surfside’s Champlain Towers South collapse, work that was recognized with a staff Pulitzer Prize for breaking news. Previously, Conarck was an investigative reporter covering criminal justice at the Florida Times-Union, where he received the Paul Tobenkin Memorial Award and the Al Nakkula Award for Police Reporting for his series with ProPublica on racial profiling by the Jacksonville Sheriff’s Office.
Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER